What is the average price target for CANTALOUPE INC (CTLP) stock?
10 analysts have analysed CTLP and the average price target is 11.42 USD. This implies a price increase of 9.11% is expected in the next year compared to the current price of 10.47.
CANTALOUPE INC (CTLP) Forecast, Price Target & Analyst Ratings
NASDAQ:CTLP • US1381031061
Current stock price
10.47 USD
-0.08 (-0.76%)
At close:
10.47 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CANTALOUPE INC (CTLP).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 6, 2026
- Period
- Q3 / 2026
- EPS Estimate
- $0.10
- Revenue Estimate
- 87.312M
Price Target Details & History
Consensus Price Target and Range
Mean target
$11.42
Upside
+ 9.11%
From current price of $10.47 to mean target of $11.42, Based on 10 analyst forecasts
Low
$11.31
Median
$11.42
High
$11.76
Price Target Revisions
1 Month
-5.88%
3 Months
-5.88%
Price Target Summary
10 Wall Street analysts provided a forecast for the next 12 months for CTLP. The average price target is 11.42 USD. This implies a price increase of 9.11% is expected in the next year compared to the current price of 10.47.
The average price target has been revised downward by 5.88% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
50.00%
CTLP was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about CTLP.
In the previous month the buy percentage consensus was at a similar level.
CTLP was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-06-17 | Benchmark | Downgrade | Buy -> Hold |
| 2025-06-16 | Barrington Research | Downgrade | Outperform -> Underperform |
| 2025-06-16 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-05-21 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-27 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-02-26 | Benchmark | Maintains | Buy -> Buy |
| 2025-02-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-02-07 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-02-03 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-11 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2024-11-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-08 | Benchmark | Maintains | Buy -> Buy |
| 2024-11-04 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-13 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-11 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-11 | Benchmark | Reiterate | Buy -> Buy |
| 2024-09-11 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-06 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-07-12 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2024-05-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-15 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-10 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-06 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2024-03-25 | Benchmark | Reiterate | Buy -> Buy |
| 2024-02-23 | Benchmark | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 6, 2026
- Period
- Q3 / 2026
- EPS Estimate
- $0.10
- Revenue Estimate
- 87.312M
- Revenue Q2Q
- 15.76%
- EPS Q2Q
- -84.31%
- Number of Analysts
- 6
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-3.44%
EPS (1 Month)
0.00%
EPS (3 Months)
-13.04%
Next Earnings Summary
CTLP is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 0.1 USD and the consensus revenue estimate is 87.31M USD.
The next earnings revenue estimate has been revised downward by 3.44% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 243.6M 18.71% | 268.596M 10.26% | 302.548M 12.64% | 351.29M 16.11% | 401.78M 14.37% | |
| EBITDA YoY % growth | 12.41M 224.02% | 26.048M 109.90% | 41.148M 57.97% | 62.73M 52.45% | 74.358M 18.54% | |
| EBIT YoY % growth | 3.6M 340.00% | 13.844M 284.56% | 23.348M 68.65% | 34.884M 49.41% | 45.696M 30.99% | |
| Operating Margin | 1.48% | 5.15% | 7.72% | 9.93% | 11.37% | |
| EPS YoY % growth | 0.02 166.67% | 0.15 650.00% | 0.85 466.67% | 0.42 -50.80% | 0.53 26.83% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 26 | Q4 / 26 | |
|---|---|---|
| EPS Q2Q % growth | 0.10 -84.31% | 0.12 36.00% |
| Revenue Q2Q % growth | 87.312M 15.76% | 94.554M 14.52% |
| EBITDA Q2Q % growth | 15.81M -21.51% | 16.932M -30.24% |
| EBIT Q2Q % growth | 8.874M 39.42% | 9.996M 54.43% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
CANTALOUPE INC / CTLP Forecast FAQ
Can you provide the upcoming earnings date for CANTALOUPE INC?
CANTALOUPE INC (CTLP) will report earnings on 2026-05-06, after the market close.
What are the consensus estimates for CANTALOUPE INC (CTLP) next earnings?
The consensus EPS estimate for the next earnings of CANTALOUPE INC (CTLP) is 0.1 USD and the consensus revenue estimate is 87.31M USD.
How do analysts rate CANTALOUPE INC (CTLP)?
The consensus rating for CANTALOUPE INC (CTLP) is 50 / 100 . This indicates that analysts generally have a neutral outlook on the stock.